Ikena Oncology, Inc.

Ikena Oncology, Inc. - Current Ratioverified

IKNA

Price:

$17.16

Market Cap:

$67.67M

Ikena Oncology, Inc. is a biopharmaceutical company specializing in precision oncology. Its primary objective is to create therapeutic agents specifically formulated for patient populations identified through biomarkers, thereby addressing significant unmet medical needs. The company's leading drug candidate is IK-930, an orally administered small molecule designed to inhibit the transcriptional enhanced associate domain (TEAD) transcription factor, a key component of the Hippo signaling pathway. Ikena is also progressing a portfolio of other investigational therapies, including: A small molecule inhibitor program targeting ERK5 within the RAS signaling pathway. IK-175, an oral compound that...[Read more]

Industry

Biotechnology

IPO Date

2021-03-26

Stock Exchange

NASDAQ

Ticker

IKNA

The Current Ratio as of June 2026 (TTM) for Ikena Oncology, Inc. (IKNA) is 18.39

According to Ikena Oncology, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 18.39. This represents a change of 27.63% compared to the average of 14.41 of the last 4 quarters.

Ikena Oncology, Inc. (IKNA) Historical Current Ratio (quarterly & annually)

How has IKNA Current Ratio performed in the past?

The mean historical Current Ratio of Ikena Oncology, Inc. over the last ten years is 8.45. The current 18.39 Current Ratio has changed 21.67% with respect to the historical average. Over the past ten years (40 quarters), IKNA's Current Ratio was at its highest in in the March 2026 quarter at 18.39. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

8.45

Median

8.07

Minimum

3.51

Maximum

12.58

Ikena Oncology, Inc. (IKNA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Ikena Oncology, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 69.02%

Maximum Annual Current Ratio = 12.58

Minimum Annual Increase = -32.88%

Minimum Annual Current Ratio = 3.51

Quarterly (TTM)
Annual
YearCurrent RatioChange
202512.495.84%
202411.80-6.19%
202312.5869.02%
20227.44-14.46%
20218.7048.50%
20205.8667.05%
20193.51-32.88%

Ikena Oncology, Inc. (IKNA) Average Current Ratio

How has IKNA Current Ratio performed in the past?

The current Current Ratio of Ikena Oncology, Inc. (IKNA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

12.29

5-year avg

10.60

10-year avg

8.45

Ikena Oncology, Inc. (IKNA) Current Ratio vs. Peers

How is IKNA’s Current Ratio compared to its peers?

Ikena Oncology, Inc.’s Current Ratio is greater than ASLAN Pharmaceuticals Limited (1.84), greater than Exscientia plc (6.22), greater than Icosavax, Inc. (16.24), greater than Avid Bioservices, Inc. (1.47), greater than Chimerix, Inc. (5.70), greater than Sage Therapeutics, Inc. (9.16), greater than Intercept Pharmaceuticals, Inc. (2.35), greater than Invivyd, Inc. (6.47), greater than iTeos Therapeutics, Inc. (7.53), greater than Niagen Bioscience Inc (4.61),

Build a custom stock screener for Ikena Oncology, Inc. (IKNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ikena Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ikena Oncology, Inc. (IKNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ikena Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Ikena Oncology, Inc.'s Current Ratio?

How is the Current Ratio calculated for Ikena Oncology, Inc. (IKNA)?

What is the highest Current Ratio for Ikena Oncology, Inc. (IKNA)?

What is the 3-year average Current Ratio for Ikena Oncology, Inc. (IKNA)?

What is the 5-year average Current Ratio for Ikena Oncology, Inc. (IKNA)?

How does the current Current Ratio for Ikena Oncology, Inc. (IKNA) compare to its historical average?